MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

No Stability Information

Guanfacine 5mg modified-release tablets (Neuraxpharm UK Ltd)

Explore other Guanfacine formulations Explore other Guanfacine 5mg modified-release tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Guanfacine 6mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Guanfacine formulations Explore other Guanfacine 6mg modified-release tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Guanfacine 6mg modified-release tablets (Neuraxpharm UK Ltd)

Explore other Guanfacine formulations Explore other Guanfacine 6mg modified-release tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Guanfacine 7mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Guanfacine formulations Explore other Guanfacine 7mg modified-release tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Guanfacine 7mg modified-release tablets (Neuraxpharm UK Ltd)

Explore other Guanfacine formulations Explore other Guanfacine 7mg modified-release tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Guardium acid reflux control 20mg gastro-resistant tablets (Reckitt Benckiser Healthcare (UK) Ltd)

Explore other Esomeprazole formulations Explore other Esomeprazole 20mg gastro-resistant tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Half Beta-Prograne 80mg modified-release capsules (Accord-UK Ltd)

Explore other Propranolol formulations Explore other Propranolol 80mg modified-release capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

Use with caution

Half Securon SR 120mg tablets (CST Pharma Ltd)

Explore other Verapamil formulations Explore other Verapamil 120mg modified-release tablets suppliers

Stability Notes

Store in airtight containers and protect from light.

Provenance

This compatibility recommendation is derived from Half Securon SR 120mg tablets (Viatris UK Healthcare Ltd).

Use with caution

Half Securon SR 120mg tablets (Pilsco Ltd)

Explore other Verapamil formulations Explore other Verapamil 120mg modified-release tablets suppliers

Stability Notes

Store in airtight containers and protect from light.

Provenance

This compatibility recommendation is derived from Half Securon SR 120mg tablets (Viatris UK Healthcare Ltd).

Use with caution

Half Securon SR 120mg tablets (Viatris UK Healthcare Ltd)

Explore other Verapamil formulations Explore other Verapamil 120mg modified-release tablets suppliers

Stability Notes

Store in airtight containers and protect from light.

Provenance

This compatibility recommendation is derived from Half Securon SR 120mg tablets (Viatris UK Healthcare Ltd).

Use with caution

Half Sinemet CR 25mg/100mg tablets (CST Pharma Ltd)

Explore other Co-careldopa formulations Explore other Co-careldopa 25mg/100mg modified-release tablets suppliers

Stability Notes

Complex dosing regime. Protect from moisture. Max 7 days in MCA.

Provenance

This compatibility recommendation is derived from Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) and Caramet 25mg/100mg CR tablets (Teva UK Ltd).

Use with caution

Half Sinemet CR 25mg/100mg tablets (Lexon (UK) Ltd)

Explore other Co-careldopa formulations Explore other Co-careldopa 25mg/100mg modified-release tablets suppliers

Stability Notes

Complex dosing regime. Protect from moisture. Max 7 days in MCA.

Provenance

This compatibility recommendation is derived from Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) and Caramet 25mg/100mg CR tablets (Teva UK Ltd).

Use with caution

Half Sinemet CR 25mg/100mg tablets (Necessity Supplies Ltd)

Explore other Co-careldopa formulations Explore other Co-careldopa 25mg/100mg modified-release tablets suppliers

Stability Notes

Complex dosing regime. Protect from moisture. Max 7 days in MCA.

Provenance

This compatibility recommendation is derived from Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) and Caramet 25mg/100mg CR tablets (Teva UK Ltd).

Use with caution

Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd)

Explore other Co-careldopa formulations Explore other Co-careldopa 25mg/100mg modified-release tablets suppliers

Stability Notes

Complex dosing regime. Protect from moisture. Max 7 days in MCA.

Provenance

This compatibility recommendation is derived from Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) and Caramet 25mg/100mg CR tablets (Teva UK Ltd).

Use with caution

Half Sinemet CR 25mg/100mg tablets (Sigma Pharmaceuticals Plc)

Explore other Co-careldopa formulations Explore other Co-careldopa 25mg/100mg modified-release tablets suppliers

Stability Notes

Complex dosing regime. Protect from moisture. Max 7 days in MCA.

Provenance

This compatibility recommendation is derived from Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) and Caramet 25mg/100mg CR tablets (Teva UK Ltd).

Print this list

Compatible

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.

Use with caution

Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.

Incompatible

Medicines under this category are not suitable for use inside MCAs.

No Stability Information

We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.